Pembroke Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Sell
722
-2
-0.3% -$1.12K 0.05% 88
2026
Q1
$407K Sell
724
-33
-4% -$21.2K 0.06% 81
2025
Q4
$512K Buy
757
+221
+41% +$151K 0.05% 73
2025
Q3
$342K Buy
536
+90
+20% +$54.6K 0.03% 77
2025
Q2
$239K Buy
+446
New +$213K 0.03% 76

Other funds holding IDXX

Pembroke Management's IDXX Position: Q2 2026 in Review

Pembroke Management reduced its Idexx Laboratories (IDXX) stake by 0.28% in Q2 2026, selling an estimated $1.12K and leaving 722 shares worth $380K. The position accounts for 0.05% of the portfolio, ranked #88.

Pembroke Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $512K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Pembroke Management held 722 shares of Idexx Laboratories worth $380K as of Q2 2026.
  • Pembroke Management sold 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
  • Idexx Laboratories made up 0.05% of Pembroke Management's portfolio in Q2 2026, its #88 holding.
  • Pembroke Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Pembroke Management's Idexx Laboratories position peaked at $512K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Pembroke Management's 13F filing for Q2 2026, filed 22 Jul 2026.